Paulus Joannes Lewi
Janssen Pharmaceutica
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Paulus Joannes Lewi.
Talanta | 2005
M. Daszykowski; I. Stanimirova; B. Walczak; Frits Daeyaert; M.R. de Jonge; Jan Heeres; Lucien Maria Henricus Koymans; Paulus Joannes Lewi; Hendrik Maarten Vinkers; Paul A. J. Janssen; D.L. Massart
The goal of this study is to derive a methodology for modeling the biological activity of non-nucleoside HIV Reverse Transcriptase (RT) inhibitors. The difficulties that were encountered during the modeling attempts are discussed, together with their origin and solutions. With the selected multivariate techniques: robust principal component analysis, partial least squares, robust partial least squares and uninformative variable elimination partial least squares, it is possible to explore and to model the contaminated data satisfactory. It is shown that these techniques are versatile and valuable tools in modeling and exploring biochemical data.
Journal of Computer-aided Molecular Design | 2003
Hendrik Maarten Vinkers; M.R. de Jonge; Frits Daeyaert; Jan Heeres; Lucien Maria Henricus Koymans; J.H. van Lenthe; Paulus Joannes Lewi; H. Timmerman; Paul A. J. Janssen
We have developed a computational approach in which an inhibitors strength is determined from its interaction energy with a limited set of amino acid residues of the inhibited protein. We applied this method to HIV protease. The method uses a consensus structure built from X-ray crystallographic data. All inhibitors are docked into the consensus structure. Given that not every ligand–protein interaction causes inhibition, we implemented a genetic algorithm to determine the relevant set of residues. The algorithm optimizes the q2 between the sum of interaction energies and the observed inhibition constants. The best possible predictive model resulting has a q2 of 0.63. External validation by examining the predictivity for compounds not used in derivation of the model leads to a prediction accuracy between 0.9 and 1.5 log10 unit. Out of 198 residues in the whole protein, the best internally predictive model defines a subset of 20 residues and the best externally predictive model one of 9 residues. These residues are distributed over the subsites of the enzyme. This approach provides insight in which interactions are important for inhibiting HIV protease and it allows for quantitative prediction of inhibitor strength.
Chemometrics and Intelligent Laboratory Systems | 1992
Paulus Joannes Lewi; H. Moereels; D. Adriaensen
Abstract Dendrograms provide the logical connectedness of the elements of a set, such as proteins that have evolved from common ancestors. The arrangement of the branches of a dendrogram is not unique and many equivalent dendrograms may represent the same logical structure. Plots of latent variables (LV) reproduce the geometrical structure of the elements in low-dimensional space. The reliability of such a low-dimensional plot is determined by how well spatial structure is preserved by the first two or three latent variables. In cases where the number of relevant latent variables is larger, the reliability of an LV plot may be low. We show that LV plots can be used for the display of logical structure even when the spatial structure is poorly represented. Applications are found in the comparison of amino acid sequences of proteins that have evolved through random mutations and natural selection. More generally, the approach is feasible when elements have evolved from one another or from unknown common ancestors. In that case, dendrograms and low-dimensional LV plots can be combined into a single display which preserves as much as possible of the logical and of the spatial structure.
Archive | 2002
Jérôme Emile Georges Guillemont; Patrice Palandjian; Marc René De Jonge; Lucien Maria Henricus Koymans; Hendrik Maarten Vinkers; Frederik Frans Desiré Daeyaert; Jan Heeres; Koen Jeanne Alfons Van Aken; Paulus Joannes Lewi; Paul A. J. Janssen
Archive | 2002
Eddy Jean Edgard Freyne; Peter Jacobus Johannes Antonius Buijnsters; Marc Willems; Werner Constant Johan Embrechts; Christopher John Love; Paul A. J. Janssen; Paulus Joannes Lewi; Jan Heeres; Marc René De Jonge; Lucien Maria Henricus Koymans; Hendrik Maarten Vinkers; Koen Jeanne Alfons Van Aken; Gaston Stanislas Marcella Diels
Archive | 2005
Jérôme Emile Georges Guillemont; Mikaël Paugam; Bruno François Marie Delest; Jan Heeres; Paulus Joannes Lewi; Paul A. J. Janssen
Archive | 2004
Jan Heeres; Paulus Joannes Lewi; Jonge Marc Rene De; Lucien Maria Henricus Koymans; Frederik Frans Desiré Daeyaert; Hendrik Maarten Vinkers; Jérôme Emile Georges Guillemont; Elisabeth Thérèse Jeanne Pasquier; Paul A. J. Janssen
Archive | 2002
Eddy Jean Edgard Freyne; Peter Jacobus Johannes Antonius Buijnsters; Marc Willems; Werner Constant Johan Embrechts; Jean Fernand Armand Lacrampe; Paul A. J. Janssen; Herwig Josephus Margareta Janssen; Paul Peter Maria Janssen; Graziella Maria Constantina Janssen; Jasmine Josee Werner Janssen; Maroussia Godelieve Frank Janssen; Theodora Joanna Francisca Arts; Paulus Joannes Lewi; Jan Heeres; Marc René De Jonge; Lucien Maria Henricus Koymans; Frederik Frans Desiré Daeyaert; Rony Nuydens; Marc Mercken
Analytica Chimica Acta | 2005
M.H. Zhang; Qing-Song Xu; Frits Daeyaert; Paulus Joannes Lewi; D.L. Massart
Archive | 2004
Paulus Joannes Lewi; Jonge Marc Rene De; Lucien Maria Henricus Koymans; Frederik Frans Desiré Daeyaert; Jan Heeres; Hendrik Maarten Vinkers; Ruben Gerardus George Leenders; Dirk Alfons Leo Vandenput; Paul A. J. Janssen